Hegazy, Doha

Publishing since 2004 (Junior)

Has published 5 publications in 6 years

Number of publications published per year by Hegazy, Doha. (Source : PubMed)

Distribution of publications types for Hegazy, Doha. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Knapp S, Warshow U, Hegazy D, Brackenbury L, Guha IN, Fowell A, Little AM, Alexander GJ, Rosenberg WM, Cramp ME, Khakoo SI. Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.  Hepatology  2009  
•  Thurairajah PH, Hegazy D, Chokshi S, Shaw S, Demaine A, Kaminski ER, Naoumov NV, Cramp ME. Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection.  J. Infect. Dis.  2008;198;12  
•  Hegazy D, Thurairajah P, Metzner M, Houldsworth A, Shaw S, Kaminski E, Demaine AG, Cramp ME. Interleukin 12B gene polymorphism and apparent resistance to hepatitis C virus infection.  Clin. Exp. Immunol.  2008;152;3  
•  Ironside JW, Bishop MT, Connolly K, Hegazy D, Lowrie S, Le Grice M, Ritchie DL, McCardle LM, Hilton DA. Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study.  BMJ  2006;332;7551  
•  Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, Penney M, Hegazy D, Ironside JW. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples.  J. Pathol.  2004;203;3  

[ See timeline ] [ See all publications ]